N/A
Completed N=36,444
Surveillance Imaging Modalities for Breast Cancer Assessment
Source: ClinicalTrials.gov NCT02212834 ↗Enrolled (actual)
36,444
Serious AEs
—
Results posted
Feb 2017
Primary outcomePrimary: Number of Breast Cancers Detected — 279; 27 cancers detected
Summary
The purpose of this study is to determine the effectiveness of surveillance breast MRI compared to mammography alone in women with a personal history of breast cancer
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Breast Cancers Detected |
279; 27 | — |
Eligibility Criteria
Inclusion Criteria: Surveillance imaging exams in women included in the Breast Cancer Surveillance Consortium who are 18+ years of age at the the of a Stage 0-III incident breast cancer diagnosis between January 1, 2005 and December 31, 2012.
-
Exclusion Criteria
- Women with a diagnosis of lobular carcinoma in situ
- Women with missing cancer staging data from Surveillance, Epidemiology and End Results (SEER) Program records
- Women with Stage 4 breast cancer at time of diagnosis
- Women with a diagnosis of a second breast cancer event within six months of the primary diagnosis
- Women who die within six months of primary diagnosis
- Women who have had a double mastectomy
Data sourced from ClinicalTrials.gov (NCT02212834). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.